Literature DB >> 15164943

Does nitric oxide contribute to iron-dependent brain injury after experimental cerebral ischaemia?

A Gámez1, T Carbonell, R Rama.   

Abstract

Experimental and clinical data suggest that iron has a key role in cerebral ischaemia. We measure infarct volume and analyse the nitric oxide responses to brain injury in rat stroke model after increased oral iron intake. Permanent middle cerebral artery occlusion (MCAO) was performed in a group of 20 male Wistar rats, 10 of which were fed with a control diet and 10 of which were fed with iron-enriched diet containing 2.5% carbonyl iron for 9 weeks. L-arginine and nitric oxide metabolites were determined in blood samples before and at 2, 6, 8 and 48 h after MCAO. Infarct volume, thiobarbituric acid reaction substances (TBARS) and tissue iron were measured at 48 h. Infarct volume was 66% greater in the iron-fed rats than in the control group. Iron-fed animals showed significantly higher levels of TBARS. Liver iron stores (3500 +/- 199 vs 352 +/- 28 microg Fe/g, p<0.0001) but not brain iron stores (131 +/- 11 vs 139 +/- 8 microg Fe/g, p=0.617), were significantly higher in the iron-fed group. L-arginine levels were slightly lower in iron-fed rats and decreased significantly in both groups at 6 and 8 hours after MCAO. The levels of the stable end products of NOS (NOx = nitrite + nitrate) were significantly higher in iron-fed rats before MCAO (16.2 +/- 2.2 vs. 9.6 +/- 0.8 micromol x L(-1), p<0.05), with a further increase during the six first hours after MCAO in both groups. These results suggest that the iron overload that increases both superoxide and nitric oxide production leads to peroxynitrite formation, thus enhancing brain damage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15164943     DOI: 10.1007/bf03179881

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  22 in total

Review 1.  Pathobiology of ischaemic stroke: an integrated view.

Authors:  U Dirnagl; C Iadecola; M A Moskowitz
Journal:  Trends Neurosci       Date:  1999-09       Impact factor: 13.837

2.  Brain tissue responses to ischemia.

Authors:  J M Lee; M C Grabb; G J Zipfel; D W Choi
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

Review 3.  Iron involvement in neural damage and microgliosis in models of neurodegenerative diseases.

Authors:  S Shoham; M B Youdim
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2000-06       Impact factor: 1.770

4.  Glutamate-induced disruption of the blood-brain barrier in rats. Role of nitric oxide.

Authors:  W G Mayhan; S P Didion
Journal:  Stroke       Date:  1996-05       Impact factor: 7.914

Review 5.  Reactive oxygen metabolites and reperfusion injury: aberrant triggering of reticuloendothelial function.

Authors:  G B Bulkley
Journal:  Lancet       Date:  1994-10-01       Impact factor: 79.321

6.  Nitric oxide-related brain damage in acute ischemic stroke.

Authors:  J Castillo; R Rama; A Dávalos
Journal:  Stroke       Date:  2000-04       Impact factor: 7.914

7.  Dietary alpha-tocopherol supplementation on antioxidant defenses after in vivo iron overload in rats.

Authors:  M Galleano; S Puntarulo
Journal:  Toxicology       Date:  1997-12-19       Impact factor: 4.221

8.  Biliary excretion of plasma non-transferrin-bound iron in rats: pathogenetic importance in iron-overload disorders.

Authors:  P Brissot; G Zanninelli; D Guyader; J Zeind; J Gollan
Journal:  Am J Physiol       Date:  1994-07

9.  Iron intake increases infarct volume after permanent middle cerebral artery occlusion in rats.

Authors:  Mar Castellanos; Nuria Puig; Teresa Carbonell; José Castillo; José Martinez; Ramón Rama; Antoni Dávalos
Journal:  Brain Res       Date:  2002-10-11       Impact factor: 3.252

10.  Iron depletion or chelation reduces ischemia/reperfusion-induced edema in gerbil brains.

Authors:  A Patt; I R Horesh; E M Berger; A H Harken; J E Repine
Journal:  J Pediatr Surg       Date:  1990-02       Impact factor: 2.545

View more
  6 in total

Review 1.  Common mechanisms of Alzheimer's disease and ischemic stroke: the role of protein kinase C in the progression of age-related neurodegeneration.

Authors:  Brandon P Lucke-Wold; Ryan C Turner; Aric F Logsdon; James W Simpkins; Daniel L Alkon; Kelly E Smith; Yi-Wen Chen; Zhenjun Tan; Jason D Huber; Charles L Rosen
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  NOx and ADMA changes with focal ischemia, amelioration with the chaperonin GroEL.

Authors:  Lijun Xu; Bingyin Wang; Kirandeep Kaur; Melanie F Kho; John P Cooke; Rona G Giffard
Journal:  Neurosci Lett       Date:  2007-03-15       Impact factor: 3.046

3.  Activation of GPR35 protects against cerebral ischemia by recruiting monocyte-derived macrophages.

Authors:  Ozayra Sharmin; Ariful Haque Abir; Abdullah Potol; Mahabub Alam; Jewel Banik; A F M Towheedur Rahman; Nuzhat Tarannum; Rasiqh Wadud; Zaki Farhad Habib; Mahbubur Rahman
Journal:  Sci Rep       Date:  2020-06-10       Impact factor: 4.379

Review 4.  Deciphering the Iron Side of Stroke: Neurodegeneration at the Crossroads Between Iron Dyshomeostasis, Excitotoxicity, and Ferroptosis.

Authors:  Núria DeGregorio-Rocasolano; Octavi Martí-Sistac; Teresa Gasull
Journal:  Front Neurosci       Date:  2019-02-19       Impact factor: 4.677

5.  Neuroprotective efficacy and therapeutic window of curcuma oil: in rat embolic stroke model.

Authors:  Preeti Dohare; Puja Garg; Uma Sharma; N R Jagannathan; Madhur Ray
Journal:  BMC Complement Altern Med       Date:  2008-09-30       Impact factor: 3.659

6.  Iron-loaded transferrin (Tf) is detrimental whereas iron-free Tf confers protection against brain ischemia by modifying blood Tf saturation and subsequent neuronal damage.

Authors:  Nuria DeGregorio-Rocasolano; Octavi Martí-Sistac; Jovita Ponce; María Castelló-Ruiz; Mònica Millán; Verónica Guirao; Isaac García-Yébenes; Juan B Salom; Pedro Ramos-Cabrer; Enrique Alborch; Ignacio Lizasoain; José Castillo; Antoni Dávalos; Teresa Gasull
Journal:  Redox Biol       Date:  2017-12-02       Impact factor: 11.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.